Literature DB >> 19021760

Structural and mutational analyses of protein-protein interactions between transthyretin and retinol-binding protein.

Giuseppe Zanotti1, Claudia Folli, Laura Cendron, Beatrice Alfieri, Sonia K Nishida, Francesca Gliubich, Nicola Pasquato, Alessandro Negro, Rodolfo Berni.   

Abstract

Transthyretin is a tetrameric binding protein involved in the transport of thyroid hormones and in the cotransport of retinol by forming a complex in plasma with retinol-binding protein. In the present study, we report the crystal structure of a macromolecular complex, in which human transthyretin, human holo-retinol-binding protein and a murine anti-retinol-binding protein Fab are assembled according to a 1 : 2 : 2 stoichiometry. The main interactions, both polar and apolar, between retinol-binding protein and transthyretin involve the retinol hydroxyl group and a limited number of solvent exposed residues. The relevance of transthyretin residues in complex formation with retinol-binding protein has been examined by mutational analysis, and the structural consequences of some transthyretin point mutations affecting protein-protein recognition have been investigated. Despite a few exceptions, in general, the substitution of a hydrophilic for a hydrophobic side chain in contact regions results in a decrease or even a loss of binding affinity, thus revealing the importance of interfacial hydrophobic interactions and a high degree of complementarity between retinol-binding protein and transthyretin. The effect is particularly evident when the mutation affects an interacting residue present in two distinct subunits of transthyretin participating simultaneously in two interactions with a retinol-binding protein molecule. This is the case of the amyloidogenic I84S replacement, which abolishes the interaction with retinol-binding protein and is associated with an altered retinol-binding protein plasma transport in carriers of this mutation. Remarkably, some of the residues in mutated human transthyretin that weaken or abolish the interaction with retinol-binding protein are present in piscine transthyretin, consistent with the lack of interaction between retinol-binding protein and transthyretin in fish.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19021760     DOI: 10.1111/j.1742-4658.2008.06705.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  14 in total

1.  Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.

Authors:  T Liu; B Zhang; X Jin; W Wang; J Lee; J Li; H Yuan; X Cheng
Journal:  Eye (Lond)       Date:  2013-10-11       Impact factor: 3.775

2.  Transthyretin binds to glucose-regulated proteins and is subjected to endocytosis by the pancreatic β-cell.

Authors:  Nancy Dekki; Essam Refai; Rebecka Holmberg; Martin Köhler; Hans Jörnvall; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Cell Mol Life Sci       Date:  2011-12-20       Impact factor: 9.261

3.  Novel Zn2+-binding sites in human transthyretin: implications for amyloidogenesis and retinol-binding protein recognition.

Authors:  Leonardo de C Palmieri; Luis Mauricio T R Lima; Juliana B B Freire; Lucas Bleicher; Igor Polikarpov; Fabio C L Almeida; Debora Foguel
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

4.  Amyloidogenic potential of transthyretin variants: insights from structural and computational analyses.

Authors:  Laura Cendron; Antonio Trovato; Flavio Seno; Claudia Folli; Beatrice Alfieri; Giuseppe Zanotti; Rodolfo Berni
Journal:  J Biol Chem       Date:  2009-07-14       Impact factor: 5.157

5.  Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease.

Authors:  Christopher L Cioffi; Nicoleta Dobri; Emily E Freeman; Michael P Conlon; Ping Chen; Douglas G Stafford; Daniel M C Schwarz; Kathy C Golden; Lei Zhu; Douglas B Kitchen; Keith D Barnes; Boglarka Racz; Qiong Qin; Enrique Michelotti; Charles L Cywin; William H Martin; Paul G Pearson; Graham Johnson; Konstantin Petrukhin
Journal:  J Med Chem       Date:  2014-09-11       Impact factor: 7.446

6.  Retinol binding protein IV purified from Escherichia coli using intein-mediated cleavage as a suitable replacement for serum sources.

Authors:  Chandler B Est; Regina M Murphy
Journal:  Protein Expr Purif       Date:  2019-11-19       Impact factor: 1.650

7.  The structure of Serratia marcescens Lip, a membrane-bound component of the type VI secretion system.

Authors:  Vincenzo A Rao; Sharon M Shepherd; Grant English; Sarah J Coulthurst; William N Hunter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-11-18

Review 8.  The interaction of zinc with the multi-functional plasma thyroid hormone distributor protein, transthyretin: evolutionary and cross-species comparative aspects.

Authors:  Kiyoshi Yamauchi
Journal:  Biometals       Date:  2021-03-09       Impact factor: 2.949

9.  Identification of Transthyretin Tetramer Kinetic Stabilizers That Are Capable of Inhibiting the Retinol-Dependent Retinol Binding Protein 4-Transthyretin Interaction: Potential Novel Therapeutics for Macular Degeneration, Transthyretin Amyloidosis, and Their Common Age-Related Comorbidities.

Authors:  Christopher L Cioffi; Arun Raja; Parthasarathy Muthuraman; Aravindan Jayaraman; Srinivasan Jayakumar; Andras Varadi; Boglarka Racz; Konstantin Petrukhin
Journal:  J Med Chem       Date:  2021-06-17       Impact factor: 8.039

10.  Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.

Authors:  Christopher L Cioffi; Parthasarathy Muthuraman; Arun Raja; Andras Varadi; Boglarka Racz; Konstantin Petrukhin
Journal:  J Med Chem       Date:  2020-09-17       Impact factor: 8.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.